Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

Summary

The primary objective of this study is to show superiority of vilaprisan in the treatment of heavy menstrual bleeding (HMB) in subjects with uterine fibroids compared to placebo.The secondary objectives of this study are to additionally evaluate the efficacy and safety of vilaprisan in subjects with uterine fibroids.

Timeline

Start

2018-10-27

Primary completion

2019-12-25

Completion

2019-12-25

Drugs

Indications